FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2769608319> ?p ?o ?g. }

• W2769608319 abstract "Escalating incidences of cancer, especially in developed and developing countries, demand evaluation of potential unexplored natural drug resources. Here, anticancer potential of 9-Ethyliminomethyl-12-(morpholin-4- ylmethoxy) -5, 8, 13, 16 – tetraaza – hexacene - 2, 3- dicarboxylic acid (EMTAHDCA) isolated from fresh water cyanobacterium Nostoc sp. MGL001 was screened through in silico, in vitro, and in vivo studies. For in silico analysis, EMTAHDCA was selected as ligand and eleven cancer related proteins (Protein Data Bank ID: 1BIX, 1NOW, 1TE6, 2RCW, 2UVL, 2VCJ, 3CRY, 3HQU, 3NMQ, 5P21, and 4B7P) which are common targets of various anticancer drugs were selected as receptors. The results obtained from in silico analysis showed that EMTAHDCA has strong binding affinity for all the eleven target protein receptors. The ability of EMTAHDCA to bind active sites of cancer protein targets indicated that it is functionally similar to commercially available anticancer drugs. For assessing cellular metabolic activities, in vitro studies were performed by using calorimetric assay viz. 3- (4, 5-dimethylthiazol- 2-yl)-2, 5 diphenyltetrazolium bromide (MTT). Results showed that EMTAHDCA induced significant cytotoxic response against Dalton’s lymphoma ascites (DLA) cells in a dose and time dependent manner with an inhibitory concentration (IC50) value of 372.4 ng/mL after 24 hours of incubation. However, in case of normal bone marrow cells, the EMTAHDCA did not induce cytotoxicity as the IC50 value was not obtained even with higher dose of 1000 ng/mL EMTAHDCA. Further, in vivo studies revealed that the median life span/survival days of tumor bearing mice treated with EMTAHDCA increased significantly with a fold change of approximately 1.9 and 1.81 corresponding to doses of 5 and 10 mg/kg body weight (B.W.) of EMTAHDCA respectively, as compared to the DL group. Our results suggest that 5 mg/kg B.W. is effective since the dose of 10 mg/kg B.W. did not show any significant difference as compared to 5 mg/kg B.W. Taken together, our findings based on in silico, in vitro, and in vivo analyses suggest that EMTAHDCA has potential anticancer effects, and thus, can be considered for cancer treatment." @default.
• W2769608319 created "2017-12-04" @default.
• W2769608319 creator A5012847618 @default.
• W2769608319 creator A5050250952 @default.
• W2769608319 creator A5065828633 @default.
• W2769608319 creator A5080206949 @default.
• W2769608319 creator A5088519178 @default.
• W2769608319 date "2017-11-27" @default.
• W2769608319 modified "2023-10-16" @default.
• W2769608319 title "The Combined Use of in Silico, in Vitro, and in Vivo Analyses to Assess Anti-cancerous Potential of a Bioactive Compound from Cyanobacterium Nostoc sp. MGL001" @default.
• W2769608319 cites W1483546674 @default.
• W2769608319 cites W1582713042 @default.
• W2769608319 cites W1661993026 @default.
• W2769608319 cites W1783075575 @default.
• W2769608319 cites W1964275052 @default.
• W2769608319 cites W1964345715 @default.
• W2769608319 cites W1965694039 @default.
• W2769608319 cites W1966361767 @default.
• W2769608319 cites W1977818536 @default.
• W2769608319 cites W1993217234 @default.
• W2769608319 cites W1999715990 @default.
• W2769608319 cites W2001301872 @default.
• W2769608319 cites W2004175162 @default.
• W2769608319 cites W2009156161 @default.
• W2769608319 cites W2021115842 @default.
• W2769608319 cites W2036119016 @default.
• W2769608319 cites W2038316411 @default.
• W2769608319 cites W2044293452 @default.
• W2769608319 cites W2049785359 @default.
• W2769608319 cites W2057117299 @default.
• W2769608319 cites W2060973672 @default.
• W2769608319 cites W2065327876 @default.
• W2769608319 cites W2065767803 @default.
• W2769608319 cites W2067278945 @default.
• W2769608319 cites W2070082953 @default.
• W2769608319 cites W2083799886 @default.
• W2769608319 cites W2084659150 @default.
• W2769608319 cites W2085238957 @default.
• W2769608319 cites W2089569798 @default.
• W2769608319 cites W2091506983 @default.
• W2769608319 cites W2093366831 @default.
• W2769608319 cites W2103996248 @default.
• W2769608319 cites W2112754550 @default.
• W2769608319 cites W2116561193 @default.
• W2769608319 cites W2119206954 @default.
• W2769608319 cites W2120993848 @default.
• W2769608319 cites W2123440974 @default.
• W2769608319 cites W2133458401 @default.
• W2769608319 cites W2134967712 @default.
• W2769608319 cites W2143857507 @default.
• W2769608319 cites W2146211839 @default.
• W2769608319 cites W2152561142 @default.
• W2769608319 cites W2152934987 @default.
• W2769608319 cites W2154792548 @default.
• W2769608319 cites W2158534713 @default.
• W2769608319 cites W2161093166 @default.
• W2769608319 cites W2168816817 @default.
• W2769608319 cites W2341769195 @default.
• W2769608319 cites W2560415540 @default.
• W2769608319 cites W2619029550 @default.
• W2769608319 doi "https://doi.org/10.3389/fphar.2017.00873" @default.
• W2769608319 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5711831" @default.
• W2769608319 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29230175" @default.
• W2769608319 hasPublicationYear "2017" @default.
• W2769608319 type Work @default.
• W2769608319 sameAs 2769608319 @default.
• W2769608319 citedByCount "9" @default.
• W2769608319 countsByYear W27696083192019 @default.
• W2769608319 countsByYear W27696083192020 @default.
• W2769608319 countsByYear W27696083192021 @default.
• W2769608319 countsByYear W27696083192022 @default.
• W2769608319 countsByYear W27696083192023 @default.
• W2769608319 crossrefType "journal-article" @default.
• W2769608319 hasAuthorship W2769608319A5012847618 @default.
• W2769608319 hasAuthorship W2769608319A5050250952 @default.
• W2769608319 hasAuthorship W2769608319A5065828633 @default.
• W2769608319 hasAuthorship W2769608319A5080206949 @default.
• W2769608319 hasAuthorship W2769608319A5088519178 @default.
• W2769608319 hasBestOaLocation W27696083191 @default.
• W2769608319 hasConcept C104317684 @default.
• W2769608319 hasConcept C109316439 @default.
• W2769608319 hasConcept C150903083 @default.
• W2769608319 hasConcept C170493617 @default.
• W2769608319 hasConcept C185592680 @default.
• W2769608319 hasConcept C202751555 @default.
• W2769608319 hasConcept C207001950 @default.
• W2769608319 hasConcept C2775905019 @default.
• W2769608319 hasConcept C2777752497 @default.
• W2769608319 hasConcept C55493867 @default.
• W2769608319 hasConcept C86803240 @default.
• W2769608319 hasConcept C98274493 @default.
• W2769608319 hasConceptScore W2769608319C104317684 @default.
• W2769608319 hasConceptScore W2769608319C109316439 @default.
• W2769608319 hasConceptScore W2769608319C150903083 @default.
• W2769608319 hasConceptScore W2769608319C170493617 @default.
• W2769608319 hasConceptScore W2769608319C185592680 @default.
• W2769608319 hasConceptScore W2769608319C202751555 @default.
• W2769608319 hasConceptScore W2769608319C207001950 @default.
• W2769608319 hasConceptScore W2769608319C2775905019 @default.
• W2769608319 hasConceptScore W2769608319C2777752497 @default.

• next